Silk Road Medical Stock Fundamentals
| SILKDelisted Stock | USD 27.49 0.00 0.00% |
Silk Road Medical fundamentals help investors to digest information that contributes to Silk Road's financial success or failures. It also enables traders to predict the movement of Silk Stock. The fundamental analysis module provides a way to measure Silk Road's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Silk Road stock.
Silk |
Silk Road Medical Company Return On Equity Analysis
Silk Road's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Silk Road Return On Equity | -0.36 |
Most of Silk Road's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Silk Road Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Silk Road Medical has a Return On Equity of -0.3645. This is 98.48% lower than that of the Health Care Equipment & Supplies sector and 95.82% lower than that of the Health Care industry. The return on equity for all United States stocks is 17.58% higher than that of the company.
Silk Road Medical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Silk Road's current stock value. Our valuation model uses many indicators to compare Silk Road value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Silk Road competition to find correlations between indicators driving Silk Road's intrinsic value. More Info.Silk Road Medical is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Silk Road by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Silk Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Silk Road's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Silk Road could also be used in its relative valuation, which is a method of valuing Silk Road by comparing valuation metrics of similar companies.Silk Road is currently under evaluation in return on equity category among its peers.
Silk Fundamentals
| Return On Equity | -0.36 | |||
| Return On Asset | -0.14 | |||
| Profit Margin | (0.30) % | |||
| Operating Margin | (0.34) % | |||
| Current Valuation | 1.02 B | |||
| Shares Outstanding | 40.63 M | |||
| Shares Owned By Insiders | 4.15 % | |||
| Shares Owned By Institutions | 97.46 % | |||
| Number Of Shares Shorted | 3.15 M | |||
| Price To Book | 7.22 X | |||
| Price To Sales | 5.83 X | |||
| Revenue | 177.13 M | |||
| Gross Profit | 100.76 M | |||
| EBITDA | (55.48 M) | |||
| Net Income | (55.74 M) | |||
| Cash And Equivalents | 108.87 M | |||
| Cash Per Share | 3.09 X | |||
| Total Debt | 84.63 M | |||
| Debt To Equity | 1.37 % | |||
| Current Ratio | 6.92 X | |||
| Book Value Per Share | 3.81 X | |||
| Cash Flow From Operations | (32.01 M) | |||
| Short Ratio | 2.48 X | |||
| Earnings Per Share | (1.45) X | |||
| Price To Earnings To Growth | (0.26) X | |||
| Target Price | 20.75 | |||
| Number Of Employees | 474 | |||
| Beta | 1.54 | |||
| Market Capitalization | 1.12 B | |||
| Total Asset | 265.31 M | |||
| Retained Earnings | (399.45 M) | |||
| Working Capital | 210.55 M | |||
| Net Asset | 265.31 M |
About Silk Road Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Silk Road Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Silk Road using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Silk Road Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Silk Road Medical, Inc. operates as a medical device company in the United States. The company was incorporated in 2007 and is headquartered in Sunnyvale, California. Silk Road operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 352 people.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Consideration for investing in Silk Stock
If you are still planning to invest in Silk Road Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Silk Road's history and understand the potential risks before investing.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Stocks Directory Find actively traded stocks across global markets |